# FTC

Type: organization

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/ftc-organization
Canonical HTML page: https://gethealthbrief.com/entity/ftc-organization

## Timeline

- **2026-03-16**: Deal Termination — Alcon and LENSAR announce the end of the merger agreement due to FTC opposition.
- **2026-02**: FTC Investigation — The FTC intensifies its review of the merger, focusing on the ophthalmic laser market.
- **2025-Q4**: Merger Agreement — Alcon and LENSAR enter into a definitive agreement for Alcon to acquire LENSAR.

## Recent coverage (2 stories)

### Clinical Consensus Rejects Marijuana as Effective Mental Health Treatment
2026-03-17 17:06:21 · Sentiment: Neutral · Impact: 6/10 · Sources: 2

A major scientific consensus has emerged indicating that marijuana does not effectively alleviate anxiety or other mental health conditions. These findings challenge the clinical foundation of medical cannabis programs in 38 states and could trigger significant regulatory shifts.
Full story: https://gethealthbrief.com/story/marijuana-mental-health-clinical-study-2026

### Alcon Abandons LENSAR Acquisition Following FTC Antitrust Challenges
2026-03-17 00:26:07 · Sentiment: Bearish · Impact: 6/10 · Sources: 5

Alcon has officially terminated its merger agreement with LENSAR, a leader in femtosecond laser technology, citing insurmountable opposition from the Federal Trade Commission (FTC). The collapse of the deal highlights increasing regulatory scrutiny over consolidation within the specialized medical device and ophthalmic surgery sectors.
Full story: https://gethealthbrief.com/story/alcon-lensar-merger-terminated-ftc

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.